InvaTech Pharma Solutions, LLC – FDA 483, May 13, 2026
An FDA inspection of InvaTech Pharma Solutions, LLC in East Brunswick, NJ, a drug manufacturer, revealed multiple significant deficiencies. These included inadequate sampling of high-risk components, failure to prevent objectionable microorganisms in non-sterile products, and issues with equipment design. Additionally, the firm lacked proper qualification of laboratory standards, failed to conduct annual visual inspections of retain samples, and exhibited poor material handling and storage practices.
ID · 16a6ca1f-3bac-43c9-9521-0ccf5e0dd14c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.